Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 13/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | DCLRE1A | Q6PJP8 | 1/20 | 0.50 |
| ▸ | DCLRE1B | Q9H816 | 1/20 | 0.50 |
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30011256 | 0.87 | FOLH1 (1.00) | FOLH1ANPEPENPEP | |
| SCHEMBL40047 | 0.87 | FOLH1 (1.00) | FOLH1ANPEPENPEP | |
| Benzene SCHEMBL1931924 | 0.83 | FOLH1 (0.70) | FOLH1TSHRDCLRE1ADCLRE1B | |
| SCHEMBL2356669 | 0.83 | FOLH1 (0.70) | FOLH1TSHRDCLRE1ADCLRE1B | |
| SCHEMBL4861257 | 0.82 | TSHR (0.70) | FOLH1TSHRKMT2A | |
| SCHEMBL7765745 | 0.81 | FOLH1 (0.54) | FOLH1TSHRKMT2A | |
| Benzoic Acid SCHEMBL28076089 | 0.75 | FOLH1 (0.70) | FOLH1TSHRANPEPENPEP | |
| Benzoic Acid SCHEMBL29974267 | 0.75 | TSHR (0.86) | FOLH1TSHR | |
| SCHEMBL7743246 | 0.74 | AKR1C3 (0.55) | FOLH1TSHRDCLRE1ADCLRE1B | |
| SCHEMBL1689462 | 0.74 | FOLH1 (0.54) | FOLH1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080311037-A1 | Compounds which bind PSMA and uses thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2008-12-18 | — | — | US | disclosed |
| WO-2006093991-A1 | COMPOUNDS WHICH BIND PSMA AND USES THEREOF | THE CLEVELAND CLINIC FOUNDATION (US) | 2006-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311037-A1 | Compounds which bind PSMA and uses thereof | FOLH1, PSMA1, BPHL | FOLH1 1/4885TSHR 4275/4885DCLRE1A 1805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.